4/11
08:00 am
crnx
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
Medium
Report
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
4/10
05:04 pm
crnx
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/1
09:51 am
crnx
Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly [Yahoo! Finance]
3/27
04:05 pm
crnx
Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly
Low
Report
Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly
3/25
08:17 am
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $60.00 price target on the stock.
Medium
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $60.00 price target on the stock.
3/10
04:36 pm
crnx
Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/1
07:36 am
crnx
Crinetics Pharmaceuticals (NASDAQ:CRNX) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals (NASDAQ:CRNX) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
2/27
05:49 pm
crnx
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
2/27
04:05 pm
crnx
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Medium
Report
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
2/27
04:01 pm
crnx
Is Crinetics Pharmaceuticals (CRNX) the Worst Performing Mid Cap Stock to Buy According to Analysts? [Yahoo! Finance]
Medium
Report
Is Crinetics Pharmaceuticals (CRNX) the Worst Performing Mid Cap Stock to Buy According to Analysts? [Yahoo! Finance]
2/24
08:41 am
crnx
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer [Yahoo! Finance]
2/24
08:30 am
crnx
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer
Medium
Report
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer
2/20
04:05 pm
crnx
Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences
Low
Report
Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences
2/11
07:26 am
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Medium
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
2/10
05:50 pm
crnx
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
2/10
04:44 pm
crnx
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/6
05:45 pm
crnx
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 [Yahoo! Finance]
Medium
Report
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 [Yahoo! Finance]
2/6
04:35 pm
crnx
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Medium
Report
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
2/4
08:22 am
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
1/22
07:39 am
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $55.00 price target on the stock.
Medium
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $55.00 price target on the stock.